← Back

Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)

This Notice of Funding Opportunity (NOFO) invites applications from clinical centers to participate in a consortium to test anti-obesity medication (AOM) treatment strategies for youth with obesity that maximize benefits and minimize risks…

Amount
up to $1M
Type
Grant

Key facts

Key facts for Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
Amountup to $1M
IssuerNational Institutes of Health
Who can applyUS companies
SectorsHealthTech
DeadlineCloses 09 Oct 2026

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: grants.gov ↗

Source checked 10 hours ago

  1. 40 days agoagentImported from the official source
Opportunities with the same funding type or region
AI Growth LabCloses 27 Sep 2026
BJA FY 2026 Adult Treatment Court Programup to $2.5MCloses 30 Oct 2026
BJA FY 2026 Capital Case Litigation Initiative: Improving the Quality of Legal Representation in State Capital Casesup to $450,000Closes 29 Oct 2026